Brokerages Set Amedisys, Inc. (NASDAQ:AMED) PT at $97.50

Shares of Amedisys, Inc. (NASDAQ:AMED - Get Free Report) have been given a consensus rating of "Hold" by the eight analysts that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $97.50.

A number of research analysts have issued reports on AMED shares. StockNews.com raised shares of Amedisys from a "hold" rating to a "buy" rating in a research note on Saturday. Cantor Fitzgerald reissued a "neutral" rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday, April 25th. Raymond James restated a "market perform" rating on shares of Amedisys in a research report on Tuesday, March 26th. Finally, Royal Bank of Canada upped their price target on shares of Amedisys from $97.00 to $100.00 and gave the stock an "outperform" rating in a research note on Monday, March 25th.

Institutional Investors Weigh In On Amedisys

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. BNP Paribas Financial Markets lifted its position in shares of Amedisys by 111.7% in the first quarter. BNP Paribas Financial Markets now owns 12,050 shares of the health services provider's stock worth $1,111,000 after buying an additional 6,358 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Amedisys by 2.6% in the 1st quarter. Principal Financial Group Inc. now owns 122,845 shares of the health services provider's stock valued at $11,321,000 after purchasing an additional 3,074 shares during the period. Louisiana State Employees Retirement System increased its holdings in shares of Amedisys by 2.2% during the 1st quarter. Louisiana State Employees Retirement System now owns 9,400 shares of the health services provider's stock worth $866,000 after purchasing an additional 200 shares during the period. Amalgamated Bank raised its position in shares of Amedisys by 7.7% during the first quarter. Amalgamated Bank now owns 21,958 shares of the health services provider's stock valued at $2,024,000 after buying an additional 1,574 shares during the last quarter. Finally, Bridge City Capital LLC lifted its stake in shares of Amedisys by 0.8% in the first quarter. Bridge City Capital LLC now owns 29,861 shares of the health services provider's stock valued at $2,752,000 after buying an additional 231 shares during the period. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Performance

Shares of AMED stock traded down $0.35 on Friday, hitting $92.08. 246,626 shares of the stock traded hands, compared to its average volume of 208,427. The company's fifty day moving average is $92.36 and its 200 day moving average is $93.32. Amedisys has a 1-year low of $73.10 and a 1-year high of $96.44. The company has a market capitalization of $3.01 billion, a PE ratio of -143.87, a PEG ratio of 3.44 and a beta of 0.84. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.09 and a quick ratio of 1.09.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, topping analysts' consensus estimates of $1.02 by $0.01. The company had revenue of $571.41 million for the quarter, compared to analysts' expectations of $565.38 million. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The firm's revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.00 earnings per share. On average, equities research analysts predict that Amedisys will post 4.57 earnings per share for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.